Bank of Montreal’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$259K Buy
+804
New +$249K ﹤0.01% 2771
2024
Q3
Sell
-6,765
Closed -$285K 4159
2024
Q2
$285K Buy
+6,765
New +$320K ﹤0.01% 2771
2022
Q4
Sell
-800
Closed -$31 4219
2022
Q3
$31 Buy
+800
New +$39.9K ﹤0.01% 3730
2021
Q2
Sell
-20
Closed -$9K 4638
2021
Q1
$9K Sell
20
-95
-83% -$67.5K ﹤0.01% 4416
2020
Q4
$101K Buy
+115
New +$67.1K ﹤0.01% 3577

Other funds holding PRAX

Bank of Montreal's PRAX Position: Q1 2026 in Review

Bank of Montreal opened a new position in Praxis Precision Medicines (PRAX) in Q1 2026: 804 shares worth $259K. The stake represents ﹤0.01% of the portfolio and ranks #2771 among its holdings. This is a return to the name: Bank of Montreal previously reported a position in PRAX as recently as Q2 2024.

Bank of Montreal first reported a position in PRAX in Q4 2020 and has held it in 5 quarters since. The position peaked at $285K in Q2 2024. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Bank of Montreal held 804 shares of Praxis Precision Medicines worth $259K as of Q1 2026.
  • Praxis Precision Medicines was a new Bank of Montreal position in Q1 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2771 holding.
  • Bank of Montreal first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 5 quarters since.
  • Bank of Montreal's Praxis Precision Medicines position peaked at $285K in Q2 2024.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.